1. Home
  2. EMN vs GKOS Comparison

EMN vs GKOS Comparison

Compare EMN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMN
  • GKOS
  • Stock Information
  • Founded
  • EMN 1920
  • GKOS 1998
  • Country
  • EMN United States
  • GKOS United States
  • Employees
  • EMN N/A
  • GKOS N/A
  • Industry
  • EMN Major Chemicals
  • GKOS Medical/Dental Instruments
  • Sector
  • EMN Industrials
  • GKOS Health Care
  • Exchange
  • EMN Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • EMN 7.0B
  • GKOS 5.8B
  • IPO Year
  • EMN 1993
  • GKOS 2015
  • Fundamental
  • Price
  • EMN $65.57
  • GKOS $89.83
  • Analyst Decision
  • EMN Buy
  • GKOS Strong Buy
  • Analyst Count
  • EMN 14
  • GKOS 12
  • Target Price
  • EMN $87.43
  • GKOS $131.17
  • AVG Volume (30 Days)
  • EMN 2.1M
  • GKOS 1.3M
  • Earning Date
  • EMN 07-31-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • EMN 5.06%
  • GKOS N/A
  • EPS Growth
  • EMN N/A
  • GKOS N/A
  • EPS
  • EMN 7.12
  • GKOS N/A
  • Revenue
  • EMN $9,286,000,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • EMN N/A
  • GKOS $27.88
  • Revenue Next Year
  • EMN $3.24
  • GKOS $27.76
  • P/E Ratio
  • EMN $9.21
  • GKOS N/A
  • Revenue Growth
  • EMN 1.52
  • GKOS 26.70
  • 52 Week Low
  • EMN $56.78
  • GKOS $77.10
  • 52 Week High
  • EMN $114.50
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • EMN 40.70
  • GKOS 43.89
  • Support Level
  • EMN $60.72
  • GKOS $88.94
  • Resistance Level
  • EMN $66.68
  • GKOS $92.70
  • Average True Range (ATR)
  • EMN 2.26
  • GKOS 3.82
  • MACD
  • EMN 0.19
  • GKOS 0.38
  • Stochastic Oscillator
  • EMN 44.02
  • GKOS 46.71

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: